The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
Big news for seniors: A new Medicare program will cover popular GLP-1 weight-loss drugs like Wegovy starting July 2026. Learn ...
The Trump administration decided to put the pilot on hold until at least 2027.